STAT

Fact-checking Trump’s claims about hydroxychloroquine, the antimalarial drug he’s touting as a coronavirus treatment

President Trump’s enthusiasm for hydroxychloroquine, the antimalarial drug still unproven as a coronavirus treatment, is only growing. Here are his boldest claims about it, annotated and fact-checked.
President Trump and Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci

WASHINGTON — President Trump can’t seem to stop talking about hydroxychloroquine.

There is currently no proven treatment for the coronavirus and Covid-19, the respiratory disease it causes, leading political figures to grasp for potentially effective stopgap measures as the global death toll nears 100,000. Hydroxychloroquine, used for decades as a medication to treat malaria and lupus, has generated by far the most excitement — within the Trump administration in particular — despite a lack of scientific evidence that it’s effective against Covid-19.

On Sunday, the debate escalated when Trump effectively prevented Anthony Fauci, the nation’s top infectious disease researcher, from answering a question about hydroxychloroquine during a White House press briefing. And over the weekend, Axios reported Fauci was berated by Trump’s economic adviser, Peter Navarro, for calling evidence supporting hydroxychloroquine’s use “anecdotal.”

Trump, it appears, has sided with his economic adviser and has repeatedly contradicted Fauci, a physician-researcher who leads the National Institute of Allergy and Infectious Diseases. He even said he would consider taking the drug himself, as a preventive measure.

The president’s has also sparked a run on the drug, in some cases preventing patients with lupus, who have relied on the drug for years, .

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Ozempic And An Eye Condition, A Failed Roche Cancer Drug Trial, And More
A study reported for the first time a potential link between Novo Nordisk's GLP-1 drugs and an eye condition that can cause vision loss.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Probing Teva Patents, A Moderna Flu Vaccine Contract, And More
The FTC is investigating Teva Pharmaceuticals after it refused to remove about two dozen patents for asthma and COPD inhalers from a federal registry.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Merck Pneumococcal Shot, Kansas Suing Pfizer, And More
In today's Pharmalittle roundup, we're reading about a Merck pneumococcal shot, Kansas suing Pfizer, and more.

Related Books & Audiobooks